Hospitalised COVID-19 patients in the UK who received an inhaled form of interferon beta-1a (SNG001) were more likely to recover and less likely to develop severe symptoms than patients who received a placebo, according to ...
Nov 13, 2020
0
1
Two studies published today in The Lancet provide fresh evidence on the issue of whether LDL cholesterol-lowering therapies, including statins, can reduce the rate of major cardiovascular events in older people.
Nov 10, 2020
0
7
Older people living with or in close contact with people of working age may be at higher risk of COVID-19 mortality in Stockholm, Sweden, according to an observational study published today in The Lancet Healthy Longevity ...
Oct 28, 2020
0
1
Collaboration and standardised approaches for assessing different vaccine efficacy endpoints are key for meaningful comparison of different COVID-19 vaccine candidates to ensure that the most effective vaccines are deployed, ...
Oct 28, 2020
0
3
Analysis suggests that individual measures (including school closure, workplace closure, public events ban, ban on gatherings of more than ten people, requirements to stay at home, and internal movement limits) are associated ...
Oct 23, 2020
0
1
A Chinese COVID-19 vaccine candidate based on the inactivated whole SARS-CoV-2 virus (BBIBP-CorV) is safe and elicits an antibody response, findings from a small early-phase randomised clinical trial published today in The ...
Oct 16, 2020
1
524
A group of 80 researchers warn that a so-called herd immunity approach to managing COVID-19 by allowing immunity to develop in low-risk populations while protecting the most vulnerable is "a dangerous fallacy unsupported ...
Oct 15, 2020
0
13
Point-of-care-testing for suspected COVID-19 reduces time to results and may improve infection control, suggesting these tests might have clinical advantages over widely used laboratory PCR methods.
Oct 9, 2020
0
1
Restricting the promotion and merchandising of unhealthy foods and beverages leads to a reduction in their sales, presenting an opportunity to improve people's diets, according to a randomised controlled trial of 20 stores ...
Oct 8, 2020
0
19
The drug combination lopinavir-ritonavir is not an effective treatment for patients admitted to hospital with COVID-19, according to the results of a randomised controlled trial published in The Lancet.
Oct 6, 2020
0
1
